MX389975B - Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa. - Google Patents

Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.

Info

Publication number
MX389975B
MX389975B MX2017005496A MX2017005496A MX389975B MX 389975 B MX389975 B MX 389975B MX 2017005496 A MX2017005496 A MX 2017005496A MX 2017005496 A MX2017005496 A MX 2017005496A MX 389975 B MX389975 B MX 389975B
Authority
MX
Mexico
Prior art keywords
therapy
blood
renal failure
solute
prediction
Prior art date
Application number
MX2017005496A
Other languages
English (en)
Inventor
Alp Akonur
Baris Ugar Agar
John Kenneth Leypoldt
Ying-Cheng Lo
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of MX389975B publication Critical patent/MX389975B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0496—Urine
    • A61M2202/0498—Urea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/15—Detection of leaks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Arrangement Of Elements, Cooling, Sealing, Or The Like Of Lighting Devices (AREA)

Abstract

Un sistema de terapia sanguínea de falla renal incluye: (i) una máquina de terapia sanguínea de falla renal; (ii) una prescripción de terapia para un paciente tratado a través de la máquina de terapia sanguínea de falla renal para remover un soluto de la sangre del paciente; (iii) una prueba que incluye múltiples muestras de sangre tomadas en múltiplos tiempos durante una terapia de prueba para determinar los niveles de concentración del soluto a cada uno de los múltiples tiempos; y (iv) un dispositivo programado para utilizar un modelo cinético para el soluto en una primera instancia con al menos uno de los niveles de concentración del soluto para estimar al menos un parámetro estimado del paciente. El dispositivo además está programado para permitir que un usuario determine al menos uno de una duración de terapia, una frecuencia de terapia, una velocidad de flujo del dializado o una velocidad de flujo de sangre para la prescripción de terapia.
MX2017005496A 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa. MX389975B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32511310P 2010-04-16 2010-04-16
PCT/US2011/032736 WO2011130669A1 (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Publications (1)

Publication Number Publication Date
MX389975B true MX389975B (es) 2025-03-20

Family

ID=44041518

Family Applications (5)

Application Number Title Priority Date Filing Date
MX2017005496A MX389975B (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2012012061A MX2012012061A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2015014313A MX347513B (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2012012062A MX2012012062A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2022001536A MX2022001536A (es) 2010-04-16 2012-10-16 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.

Family Applications After (4)

Application Number Title Priority Date Filing Date
MX2012012061A MX2012012061A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2015014313A MX347513B (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2012012062A MX2012012062A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2022001536A MX2022001536A (es) 2010-04-16 2012-10-16 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.

Country Status (10)

Country Link
EP (3) EP3706134A1 (es)
JP (8) JP5747072B2 (es)
AU (2) AU2011239489B2 (es)
BR (1) BR112012026361A2 (es)
CA (2) CA2796505C (es)
CO (3) CO6660434A2 (es)
ES (2) ES2501715T3 (es)
MX (5) MX389975B (es)
NZ (2) NZ603010A (es)
WO (2) WO2011130668A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8845570B2 (en) 2010-04-16 2014-09-30 Baxter International Inc. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
US9132219B2 (en) 2010-04-16 2015-09-15 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
ES2717130T3 (es) * 2013-08-16 2019-06-19 Baxter Int Optimización de terapia de potasio sérico para hemoterapia de insuficiencia renal, especialmente hemodiálisis domiciliaria
DE102014005122A1 (de) * 2014-04-08 2015-10-08 Fresenius Medical Care Deutschland Gmbh Verfahren zur Abschätzung der Behandlungsdauer einer Pertionealdialyse-Behandlung
EP3539586B1 (en) 2014-10-10 2022-08-24 NxStage Medical Inc. Flow balancing methods
WO2018017623A1 (en) 2016-07-18 2018-01-25 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US11865243B2 (en) 2016-08-30 2024-01-09 Nxstage Medical, Inc. Parameter monitoring in medical treatment systems
JP2019212249A (ja) * 2018-06-10 2019-12-12 大 益満 プログラム及び情報処理システム
US12230403B2 (en) 2019-03-11 2025-02-18 Fresenius Medical Care Holdings, Inc. Techniques for determining acid-base homeostasis
WO2020237228A1 (en) 2019-05-23 2020-11-26 Nxstage Medical, Inc. Flow synchronization devices, methods and systems
CN115050238B (zh) * 2022-07-08 2024-03-12 卡斯柯信号有限公司 一种基于真实ctc系统的多模式切换仿真实训系统
JP2024113409A (ja) 2023-02-09 2024-08-22 フィジオロガス・テクノロジーズ株式会社 診療支援システム
JPWO2024242176A1 (es) 2023-05-25 2024-11-28

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5230702A (en) * 1991-01-16 1993-07-27 Paradigm Biotechnologies Partnership Hemodialysis method
CA2124808A1 (en) * 1992-10-13 1994-04-28 Vernon H. Troutner Fluid sampling module
JP2812460B2 (ja) * 1995-10-04 1998-10-22 日機装株式会社 血液浄化モニタ装置
JP3402360B2 (ja) * 1998-08-21 2003-05-06 株式会社ジェイ・エム・エス 腹膜透析システム
AUPP790898A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
ES2245723T5 (es) * 2002-09-05 2013-09-10 Gambro Lundia Ab Controlador para un equipo de tratamiento de sangre
US20040048837A1 (en) * 2002-09-06 2004-03-11 Lazarus J. Michael Method for treatment of renal disease
JP4379027B2 (ja) * 2003-05-14 2009-12-09 株式会社ジェイ・エム・エス 腹膜透析および血液透析併用プランニング方法ならびに腹膜透析および血液透析併用プランニング装置
ATE464611T1 (de) * 2005-06-09 2010-04-15 Gambro Lundia Ab Medizinische vorrichtung und verfahren zum einrichten einer medizinischen vorrichtung
DE102006045437A1 (de) * 2006-09-26 2008-04-03 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Vorgabe einer Dialysierflüssigkeitsrate oder Blutflussrate für eine extrakorporale Blutbehandlung
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US8562834B2 (en) 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
US8409441B2 (en) * 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
US8888470B2 (en) 2007-02-27 2014-11-18 Deka Products Limited Partnership Pumping cassette
US8393690B2 (en) * 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
EP2174292A1 (en) * 2007-08-03 2010-04-14 Koninklijke Philips Electronics N.V. A method, apparatus, computer-readable medium and use for pharmacokinetic modeling
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US7981281B2 (en) 2008-07-09 2011-07-19 Baxter International, Inc. Dialysis system having regimen generation methodology
US8168063B2 (en) 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
US8062513B2 (en) * 2008-07-09 2011-11-22 Baxter International Inc. Dialysis system and machine having therapy prescription recall
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
EP2163272B1 (en) * 2008-09-15 2014-06-25 B. Braun Avitum AG Device to early predict the Kt/V parameter in kidney substitution treatments
EP2334292B1 (en) * 2008-10-17 2019-05-08 Fresenius Medical Care Holdings, Inc. Method of determining a phosphorus binder dosage for a dialysis patient

Also Published As

Publication number Publication date
CO6630153A2 (es) 2013-03-01
NZ602996A (en) 2015-02-27
JP6543279B2 (ja) 2019-07-10
JP6078582B2 (ja) 2017-02-08
JP7438257B2 (ja) 2024-02-26
JP2022095842A (ja) 2022-06-28
JP2015165914A (ja) 2015-09-24
EP2558966A1 (en) 2013-02-20
AU2011239489A1 (en) 2012-11-08
EP2558967A1 (en) 2013-02-20
JP2017094150A (ja) 2017-06-01
JP7057321B2 (ja) 2022-04-19
MX2012012062A (es) 2013-06-28
AU2011239489B2 (en) 2015-04-02
BR112012026361A2 (pt) 2019-09-24
AU2011239488A1 (en) 2012-11-08
JP5747072B2 (ja) 2015-07-08
JP2019188179A (ja) 2019-10-31
MX2022001536A (es) 2022-05-26
EP2558966B1 (en) 2014-07-16
CO6620023A2 (es) 2013-02-15
MX347513B (es) 2017-04-28
JP6043850B2 (ja) 2016-12-14
JP6018567B2 (ja) 2016-11-02
WO2011130669A1 (en) 2011-10-20
EP3706134A1 (en) 2020-09-09
ES2501715T3 (es) 2014-10-02
JP2013524892A (ja) 2013-06-20
EP2558967B1 (en) 2020-04-15
WO2011130668A1 (en) 2011-10-20
JP2024045513A (ja) 2024-04-02
AU2011239488B2 (en) 2015-05-21
JP2013524893A (ja) 2013-06-20
CA2796505C (en) 2018-12-11
CA2796496A1 (en) 2011-10-20
NZ603010A (en) 2014-05-30
CO6660434A2 (es) 2013-04-30
CA2796505A1 (en) 2011-10-20
CA2796496C (en) 2018-03-20
MX2012012061A (es) 2013-06-28
ES2802609T3 (es) 2021-01-20
JP2015221383A (ja) 2015-12-10

Similar Documents

Publication Publication Date Title
MX389975B (es) Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
BR112013026319A2 (pt) método e aparelho para o monitoramento de um tratamento de um paciente, preferivelmente para o monitoramento da hemodiálise, hemodiafiltração e/ou diálise peritoneal
MX2015012556A (es) Sistema y metodo para intercambio de dialisis peritoneal teniendo una unidad energizante reutilizable.
MY199017A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy
EA201492106A1 (ru) Способ и устройство для контроля экстракорпоральной обработки крови пациента
PL1993632T3 (pl) Urządzenie i sposób nadzoru dostępu do pacjenta, zwłaszcza dostępu do naczynia przy pozaustrojowej obróbce krwi
PL2395961T3 (pl) Urządzenie do wykrywania wilgoci dla urządzenia do nadzoru dostępu do pacjenta, zwłaszcza do nadzoru dostępu do naczynia przy pozaustrojowej obróbce krwi
WO2013101292A3 (en) Fluid volume monitoring for patients with renal disease
MY175997A (en) Antl-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
SG11201402358RA (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
MX2016002083A (es) Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.
SG10201600502XA (en) Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
BR112013007046A2 (pt) método para a otimização do consumo de dialisato em uma unidade de tratamento sanguíneo e aparato para o tratamento sanguíneo
Lai et al. Group sequential designs for developing and testing biomarker-guided personalized therapies in comparative effectiveness research
TN2014000132A1 (en) Dosage regimen for an s1p receptor modulator or agonist
ATE420678T1 (de) Dialysemaschine mit einer einrichtung zur bestimmung der dialysedosis
UA77634U (ru) Способ консервативного лечения венозных тромбозов
Jang et al. Transcutaneous oxygen pressure to predict wound healing in mild diabetic feet
RU2010154218A (ru) Способ лечения поздней кожной порфирии у больного зависимого от гемодиализа
张承磊 The treatment strategy of special distal landing zones in endovascular repair of abdominal aortic aneurysm
UA48015U (ru) Способ улучшения результатов лечения больных с повторной легкой черепно-мозговой травмой с использованием принципа "дорожной карты"
UA72258U (ru) Способ сорбционной детоксикации организма
UA65684U (ru) Способ определения повышенного уровня сенсибилизации организма
Reissig Tussive irritation, epistaxis and lassitude in an elderly patient: case report
UA54000U (uk) Спосіб дренування черевної порожнини при перитоніті